Blood and Lymphatic Cancer: Targets and Therapy

ISSN: 1179-9889

Editor-in-Chief: Dr David Dingli

An international, peer reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Indexed online:

• PubMed and PubMed Central (Blood Lymphat Cancer)
• Emerging Sources Citation Index (ESCI), from 2016
• Embase, From 2011 (Correct as at December 8, 2016)
• Directory of Open Access Journals (DOAJ)
• OAIster: The Open Access initiative